2026 Q1 Business Overview Presentation via Meritz Securities NDR
- Participating in Meritz Securities NDR to present 2026 Q1 business status and Q&A
- Date: 2026-05-08 09:10, Location: Seoul, Audience: Domestic institutional investors, Format: 1:1 meetings
- IR materials to be posted on company IR page (2026-04-30)
ADVERTISEMENT (250px+)
KOSPI Filing Information
- Filing: Corporate Briefing (IR) Holding (Notice Disclosure)
- Company: Hanmi Pharm (128940)
- Submission: Hanmi Pharm. Co., Ltd.
- Receipt: 04-30-2026
- Under KRX KOSPI Market Division